ES507072A0 - Procedimiento para la preparacion de derivados de benzofura-no 2-sustituidos. - Google Patents

Procedimiento para la preparacion de derivados de benzofura-no 2-sustituidos.

Info

Publication number
ES507072A0
ES507072A0 ES507072A ES507072A ES507072A0 ES 507072 A0 ES507072 A0 ES 507072A0 ES 507072 A ES507072 A ES 507072A ES 507072 A ES507072 A ES 507072A ES 507072 A0 ES507072 A0 ES 507072A0
Authority
ES
Spain
Prior art keywords
benzofura
derivatives
substituted
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES507072A
Other languages
English (en)
Other versions
ES8307781A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Menarini SAS
Original Assignee
Menarini SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini SAS filed Critical Menarini SAS
Publication of ES507072A0 publication Critical patent/ES507072A0/es
Publication of ES8307781A1 publication Critical patent/ES8307781A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/92—Naphthofurans; Hydrogenated naphthofurans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/86—Benzo [b] furans; Hydrogenated benzo [b] furans with an oxygen atom directly attached in position 7

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES507072A 1980-11-12 1981-11-12 Procedimiento para la preparacion de derivados de benzofura-no 2-sustituidos. Expired ES8307781A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT09583/80A IT1154888B (it) 1980-11-12 1980-11-12 Derivati del benzofurano 2-sostituiti e relativi metodi di preparazione

Publications (2)

Publication Number Publication Date
ES507072A0 true ES507072A0 (es) 1983-08-16
ES8307781A1 ES8307781A1 (es) 1983-08-16

Family

ID=11132470

Family Applications (1)

Application Number Title Priority Date Filing Date
ES507072A Expired ES8307781A1 (es) 1980-11-12 1981-11-12 Procedimiento para la preparacion de derivados de benzofura-no 2-sustituidos.

Country Status (14)

Country Link
US (2) US4485112A (es)
JP (1) JPS57109774A (es)
BE (1) BE891092A (es)
CA (1) CA1182454A (es)
CH (1) CH653679A5 (es)
DE (1) DE3145004A1 (es)
DK (1) DK153788C (es)
ES (1) ES8307781A1 (es)
FR (1) FR2493845B1 (es)
GB (1) GB2091719B (es)
GR (1) GR76933B (es)
IT (1) IT1154888B (es)
NL (1) NL8105121A (es)
SE (1) SE451328B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2550091B1 (fr) * 1983-08-02 1986-05-23 Sanofi Sa Composition pharmaceutique ou veterinaire destinee a combattre des troubles ischemiques cardiaques contenant un derive du benzofuranne
US5087638A (en) * 1984-06-20 1992-02-11 Merck Frosst Canada, Inc. Benzofuran derivatives
CA1281325C (en) * 1984-06-20 1991-03-12 Patrice C. Belanger Benzofuran derivatives
IT1216256B (it) * 1986-08-13 1990-02-22 Menarini Sas (benzofuran-2-il) imidazoli, con attivita' farmacologica,loro sali e procedimenti di fabbricazione relativi.
US4956382A (en) * 1987-02-07 1990-09-11 Pfizer Inc. Sulfonamide anti-arrhythmic agents
US4806663A (en) * 1987-04-06 1989-02-21 The University Of Tennessee Research Corporation Certain 3-substituted 2-alkyl benzofuran derivatives
US4851554A (en) * 1987-04-06 1989-07-25 University Of Tennessee Research Corporation Certain 3-substituted 2-alkyl benzofuran derivatives
US4831156A (en) * 1987-09-30 1989-05-16 The University Of Tennessee Research Corp. 3-substituted 2-alkyl indole derivatives
WO1989002893A1 (en) * 1987-09-30 1989-04-06 The University Of Tennessee Research Corporation Certain 3-substituted 2-alkyl benzothiophene derivatives
US4975458A (en) * 1989-03-13 1990-12-04 Taro Pharmaceuticals Industries, Ltd. 2-alkyl-3-benzoylbenzofurans useful for treating cardiac arrhythmia
WO1993001180A1 (en) * 1991-07-09 1993-01-21 Nippon Shinyaku Co., Ltd. Benzofuran derivative and pharmaceutical composition
FR2708609B1 (fr) * 1993-07-29 1995-10-20 Sanofi Elf Dérivés de méthylguanidine, leurs procédés de préparation ainsi que les compositions en contenant.
US6395755B1 (en) * 1995-03-10 2002-05-28 Eli Lilly And Company Benzothiophene pharmaceutical compounds
US6653328B1 (en) * 1995-03-10 2003-11-25 Eli Lilly And Company 3-benzyl-benzothiophenes
US6417199B1 (en) * 1995-03-10 2002-07-09 Eli Lilly And Company 3-benzyl-benzothiophenes
EP1551392A4 (en) * 2002-09-17 2006-09-20 Arqule Inc NOVEL LAPACHO COMPOUNDS AND METHODS OF USE THEREOF
EP2447263A1 (en) * 2010-09-27 2012-05-02 Bioprojet Benzazole derivatives as histamine H4 receptor ligands
US20210130312A1 (en) * 2018-04-03 2021-05-06 Children's Hospital Medical Center Inhibitors of eya3-protein tyrosine phosphatase in dna damage repair signaling of pulmonary arterial hypertension

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3156688A (en) * 1962-11-05 1964-11-10 Abbott Lab Nu-alkyl and nu-aralkyl benzoxacycloalkanemethylamines
DE1492403A1 (de) * 1965-03-30 1969-12-04 Merck Ag E UV-Lichtschutzmittel fuer kosmetische Zwecke
GB1160925A (en) * 1967-02-08 1969-08-06 Menarini Sas 2-Substituted Benzofuran Derivatives
US3880891A (en) * 1973-09-21 1975-04-29 Smithkline Corp Substituted benzofurans
US4024273A (en) * 1974-06-20 1977-05-17 Smithkline Corporation Coronary vasodilator and anti-anginal compositions comprising substituted benzofurans and benzothiophenes and methods of producing coronary vasodilation and anti-anginal activity
US3983245A (en) * 1975-02-06 1976-09-28 Smithkline Corporation Certain 4-(3-azacycloalkoxy or azacycloalkylmethoxy)benzoylbenzofurans or benzothiophenes

Also Published As

Publication number Publication date
CA1182454A (en) 1985-02-12
GB2091719B (en) 1985-06-05
NL8105121A (nl) 1982-06-01
IT8009583A0 (it) 1980-11-12
FR2493845B1 (fr) 1985-07-05
SE451328B (sv) 1987-09-28
DE3145004A1 (de) 1982-06-16
CH653679A5 (it) 1986-01-15
DK501181A (da) 1982-05-13
GR76933B (es) 1984-09-04
DK153788B (da) 1988-09-05
GB2091719A (en) 1982-08-04
SE8106733L (sv) 1982-05-13
US4604392A (en) 1986-08-05
DK153788C (da) 1989-01-23
JPS57109774A (en) 1982-07-08
BE891092A (fr) 1982-03-01
JPH0245629B2 (es) 1990-10-11
ES8307781A1 (es) 1983-08-16
US4485112A (en) 1984-11-27
FR2493845A1 (fr) 1982-05-14
IT1154888B (it) 1987-01-21

Similar Documents

Publication Publication Date Title
ES520180A0 (es) Procedimiento para la preparacion de nuevos derivados de la aminometil-5-aril-3-oxazolidinona-2.
ES517167A0 (es) Procedimiento para la preparacion de nuevos bencimidazoles sustituidos.
ES514585A0 (es) Procedimiento para la obtencion de derivados de oxazol trisustituidos.
ES507324A0 (es) Procedimiento para la preparacion de derivados de urea.
ES514795A0 (es) Procedimiento para la preparacion de derivados substituidos de la piridazina.
ES505472A0 (es) Procedimiento para la preparacion de compuestos frugicidas.
ES504791A0 (es) Procedimiento para la preparacion de derivados de caprolactama.
ES524185A0 (es) Procedimiento para la preparacion de nuevos derivados de pirimidina o s-triacina.
ES507667A0 (es) Procedimiento para la preparacion de 8-arilalcohil-3-fenil-3-nortropanoles .
ES507072A0 (es) Procedimiento para la preparacion de derivados de benzofura-no 2-sustituidos.
ES514887A0 (es) Procedimiento para la preparacion de derivados de la piridazina.
ES507635A0 (es) Procedimiento para la preparacion de nuevas fenilalcohilaminas .
ES516864A0 (es) Procedimiento para la preparacion de derivados de penem.
ES517030A0 (es) Procedimiento para la preparacion de derivados de eburnamonina.
ES513792A0 (es) Procedimiento para la preparacion de amidobenzamidas.
AR227906A1 (es) Procedimiento para la preparacion de derivados de 1-fenil-2-ciclohexen-1-alquilamina
ES518274A0 (es) Procedimiento para la preparacion de derivados de tiazolina.
ES507468A0 (es) Procedimiento para la preparacion de acilureas.
ES513392A0 (es) Procedimiento para la obtencion de derivados de 2-amino-piridina sustituidos.
ES520537A0 (es) Procedimiento para la preparacion de derivados de carbaciclina.
ES502212A0 (es) Procedimiento para la preparacion de n-di-n-propil-2,6-dini-tro-4-trifluorometilanilina
ES517288A0 (es) Procedimiento para la preparacion de derivados de azolil-penteno.
ES513169A0 (es) Procedimiento para la obtencion de nuevos derivados de benzazol.
ES518858A0 (es) Procedimiento para la fabricacion de derivados de tetrahidrobenzotiazol.
ES517888A0 (es) Procedimiento para la preparacion de tioalcanoil-carnitinas.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20000201